Scarica l'app Stockscreener
1.89
3.08%
-0.06
Dopo l'orario di chiusura:
1.90
0.01
+0.53%
Precedente Chiudi:
$1.95
Aprire:
$1.99
Volume 24 ore:
117.30K
Relative Volume:
0.45
Capitalizzazione di mercato:
$54.98M
Reddito:
$63.15M
Utile/perdita netta:
$-40.30M
Rapporto P/E:
-1.1317
EPS:
-1.67
Flusso di cassa netto:
$-44.47M
1 W Prestazione:
+35.97%
1M Prestazione:
+95.85%
6M Prestazione:
-36.36%
1 anno Prestazione:
-66.96%
Intervallo 1D:
$1.82
$1.99
Intervallo di 1 settimana:
$1.30
$2.01
Portata 52W:
$0.8645
$5.80
Tela Bio Inc Stock (TELA) Company Profile
Nome
Tela Bio Inc
Settore
Industria
Telefono
484-320-2930
Indirizzo
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Confronta TELA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
1.89 | 54.98M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | Iniziato | Lake Street | Buy |
| 2019-12-03 | Iniziato | Canaccord Genuity | Buy |
| 2019-12-03 | Iniziato | JMP Securities | Mkt Outperform |
| 2019-12-03 | Iniziato | Jefferies | Buy |
| 2019-12-03 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Tela Bio Inc Borsa (TELA) Ultime notizie
Tela Bio Announces Inducement Grant Under Nasdaq Listing Rule - marketscreener.com
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 56 - GuruFocus
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
TELA Bio Grants 105,000 Shares in Options and RSUs to New Strategic Operations SVP | TELA Stock News - Stock Titan
NORTH RUN CAPITAL, LP Acquires Significant Stake in TELA Bio Inc - GuruFocus
Tela Bio Announces OviTex Inguinal Reinforced Tissue Matri’s European Debut - MSN
TELA Bio Launches OviTex Reinforced Tissue Matrix for Hernia Repair in Europe - MyChesCo
Northern Trust Corp Has $142,000 Position in TELA Bio, Inc. (NASDAQ:TELA) - Defense World
TELA Bio launches OviTex Inguinal in Europe for hernia repair By Investing.com - Investing.com South Africa
TELA Bio Launches Tissue Matrix in Europe for Inguinal Hernia Repair - marketscreener.com
Tela Bio (TELA) Debuts OviTex Inguinal Matrix in Europe | TELA Stock News - GuruFocus
TELA Bio Announces European Commercial Launch of OviTex® Inguina - GuruFocus
TELA Bio launches OviTex Inguinal in Europe for hernia repair - Investing.com Australia
TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair - The Manila Times
TELA Bio Announces European Commercial Launch of OviTex® - GlobeNewswire
European Launch: TELA Bio's Natural Hernia Repair Device Shows 98.8% Success Rate - Stock Titan
TELA Bio Appoints Jeffrey Blizard as President - GlobeNewswire
TELA Bio names Jeffrey Blizard as new president By Investing.com - Investing.com South Africa
TELA Bio Names Jeffrey Blizard as President to Drive Strategic Growth - MyChesCo
TELA Bio names Jeffrey Blizard as new president - Investing.com India
TELA Bio Appoints Jeffrey Blizard as President | TELA Stock News - GuruFocus
Tela Bio appoints Jeffrey Blizard as president, effective immediately - TipRanks
TELA Bio Announces Leadership Change with New President - TipRanks
Johnson & Johnson's Former Executive Joins TELA Bio in Leadership Role | JNJ Stock News - GuruFocus
TELA Bio Appoints Jeffrey Blizard as President to Drive Growth and Innovation - Nasdaq
Strategic Power Move: TELA Bio Taps J&J Executive to Accelerate MedTech Growth Strategy - Stock Titan
TELA Bio Approves Key Proposals at Annual Meeting - TipRanks
TELA Bio’s SWOT analysis: biologic innovator faces growth hurdles By Investing.com - Investing.com Nigeria
TELA Bio’s SWOT analysis: biologic innovator faces growth hurdles - Investing.com
TELA Bio to Present at the 2025 Jefferies Global Healthcare Conference - MSN
TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference | TELA Stock News - GuruFocus
TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference - GlobeNewswire
TELA Bio Brings Soft-Tissue Innovation Spotlight to Jefferies Healthcare Conference 2025 - Stock Titan
Investors Still Aren't Entirely Convinced By TELA Bio, Inc.'s (NASDAQ:TELA) Revenues Despite 39% Price Jump - simplywall.st
Piper Sandler maintains TELA Bio stock at Neutral with $2 target - Investing.com Australia
Cubist Systematic Strategies LLC Acquires 15,283 Shares of TELA Bio, Inc. (NASDAQ:TELA) - Defense World
TELA Bio Reports Q1 2025 Growth and Product Expansion - MSN
TELA Bio Announces Inducement Grants to New Hires with 4-Year Vesting Plan - MSN
TELA Bio announces inducement grants - Medical Buyer
TELA Bio, Inc. (NASDAQ:TELA) Q1 2025 Earnings Call Transcript - Insider Monkey
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5 - GuruFocus
TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates - MSN
TELA Bio’s Earnings Call: Growth Amid Challenges - TipRanks
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | TELA Stock News - GuruFocus
TELA Bio revenue up 12% to USD 18.5 million in Q1 2025 - Medical Buyer
TELA Bio Inc (TELA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Challenges - Yahoo Finance
TELA Bio Reports First Quarter 2025 Financial Results - The Manila Times
TELA Bio Inc (TELA) Q1 2025 Earnings Call Highlights: Strong Rev - GuruFocus
TELA Bio (NASDAQ:TELA) vs. Inspire Medical Systems (NYSE:INSP) Critical Contrast - The AM Reporter
TELA Bio Reports Strong Q1 2025 Revenue Growth - TipRanks
Tela Bio Inc Azioni (TELA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.56%
1.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):